Phase 1 PARKINSON DISEASE (Disorder) trials recruiting now

All PARKINSON DISEASE (Disorder) trials, every phase

Other phases for PARKINSON DISEASE (Disorder)

Phase 1 PARKINSON DISEASE (Disorder) trials

• A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)
  NCT07666022 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
  NCT07422675 · Phase: Phase 1 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 6 locations
• Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
  NCT07461220 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 14 locations
• Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
  NCT07557706 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
  NCT07182058 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.